Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25	1.00e-09	37	108	7	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25	1.22e-09	38	108	7	GO:0070001
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	1.90e-09	11	108	5	GO:0004523
GeneOntologyMolecularFunction	non-membrane spanning protein tyrosine kinase activity	SRC PKDCC YES1 BLK PEAK1 FGR HCK	5.00e-09	46	108	7	GO:0004715
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	8.12e-09	14	108	5	GO:0003964
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	8.01e-08	21	108	5	GO:0035613
GeneOntologyMolecularFunction	triplex DNA binding	DDX12P DDX11 DDX11L8	6.13e-07	4	108	3	GO:0045142
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.20e-06	35	108	5	GO:0015020
GeneOntologyMolecularFunction	protein tyrosine kinase activity	FLT1 SRC PKDCC YES1 BLK PEAK1 FGR HCK	1.22e-06	145	108	8	GO:0004713
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	1.60e-06	37	108	5	GO:0016891
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	1.84e-06	38	108	5	GO:0034061
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	ERVK-6 FLT1 SRC PKDCC SNRK ERVK-7 ALPK1 ERVK-10 YES1 BLK STK3 LIMK2 BUB1 ERVK-8 PEAK1 FGR ERVK-11 HCK	2.70e-06	938	108	18	GO:0016772
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	4.84e-06	46	108	5	GO:0016893
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	ERVK-6 DDX12P ERVK-7 ERVK-10 CRY1 DDX11 ERVK-8 ERVK-11 DDX11L8	1.27e-05	262	108	9	GO:0140097
GeneOntologyMolecularFunction	protein kinase activity	FLT1 SRC PKDCC SNRK ALPK1 YES1 BLK STK3 LIMK2 BUB1 PEAK1 FGR HCK	2.16e-05	600	108	13	GO:0004672
GeneOntologyMolecularFunction	5'-3' DNA helicase activity	DDX12P DDX11 DDX11L8	2.46e-05	11	108	3	GO:0043139
GeneOntologyMolecularFunction	G-quadruplex DNA binding	DDX12P DDX11 DDX11L8	5.36e-05	14	108	3	GO:0051880
GeneOntologyMolecularFunction	RNA endonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	6.91e-05	79	108	5	GO:0004521
GeneOntologyMolecularFunction	catalytic activity, acting on RNA	DDX19B ERVK-6 DDX12P AZGP1 ERVK-7 ERVK-10 ERVK-8 TRMT13 ERVK-11 DDX11L8	8.88e-05	417	108	10	GO:0140098
GeneOntologyMolecularFunction	RNA nuclease activity	ERVK-6 AZGP1 ERVK-7 ERVK-10 ERVK-8 ERVK-11	9.68e-05	136	108	6	GO:0004540
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	FLT1 SRC PKDCC SNRK ALPK1 YES1 BLK STK3 LIMK2 BUB1 PEAK1 FGR HCK	1.18e-04	709	108	13	GO:0016773
GeneOntologyMolecularFunction	DNA replication origin binding	DDX12P DDX11 DDX11L8	1.18e-04	18	108	3	GO:0003688
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	DDX19B ERVK-6 DDX12P AZGP1 ERVK-7 ERVK-10 CRY1 DDX11 ERVK-8 TRMT13 ERVK-11 DDX11L8	1.92e-04	645	108	12	GO:0140640
GeneOntologyMolecularFunction	kinase activity	FLT1 SRC PKDCC SNRK ALPK1 YES1 BLK STK3 LIMK2 BUB1 PEAK1 FGR HCK	2.46e-04	764	108	13	GO:0016301
GeneOntologyMolecularFunction	transition metal ion binding	ERVK-6 APOBEC3D ZNF184 AOC2 ERVK-7 ERVK-10 CA10 F8 ARG2 SMPDL3B TRIM17 ERVK-8 ERVK-19 ERVK-11 NOS3 SOD1	6.45e-04	1189	108	16	GO:0046914
GeneOntologyMolecularFunction	ATP hydrolysis activity	DDX19B DDX12P RNF213 DDX11 HSPA1L HSPA2 ATP2B2 HSPA7 DDX11L8	6.55e-04	441	108	9	GO:0016887
GeneOntologyMolecularFunction	endonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	8.66e-04	136	108	5	GO:0004519
GeneOntologyMolecularFunction	ATP-dependent activity, acting on RNA	DDX19B DDX12P DDX11 DDX11L8	9.33e-04	80	108	4	GO:0008186
GeneOntologyMolecularFunction	ATP-dependent protein folding chaperone	HSPA1L HSPA2 HSPA7	1.31e-03	40	108	3	GO:0140662
GeneOntologyMolecularFunction	nucleotidyltransferase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	1.42e-03	152	108	5	GO:0016779
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.46e-03	153	108	5	GO:0008194
GeneOntologyMolecularFunction	nuclease activity	ERVK-6 AZGP1 ERVK-7 ERVK-10 ERVK-8 ERVK-11	1.61e-03	231	108	6	GO:0004518
GeneOntologyMolecularFunction	4 iron, 4 sulfur cluster binding	DDX12P DDX11 DDX11L8	2.10e-03	47	108	3	GO:0051539
GeneOntologyMolecularFunction	endopeptidase activity	ERVK-6 ERVK-7 ERVK-10 F3 ERVK-8 ERVK-18 ERVK-19 ERVK-25	2.34e-03	430	108	8	GO:0004175
GeneOntologyMolecularFunction	titin binding	MYBPC1 MYBPC3	2.53e-03	14	108	2	GO:0031432
GeneOntologyMolecularFunction	phosphotyrosine residue binding	YES1 FGR HCK	2.65e-03	51	108	3	GO:0001784
GeneOntologyMolecularFunction	SH2 domain binding	LILRA1 SRC ARHGAP5	2.80e-03	52	108	3	GO:0042169
GeneOntologyMolecularFunction	chloride channel regulator activity	ANO9 CHRNA7	2.91e-03	15	108	2	GO:0017081
GeneOntologyMolecularFunction	zinc ion binding	ERVK-6 APOBEC3D ZNF184 ERVK-7 ERVK-10 CA10 SMPDL3B TRIM17 ERVK-8 ERVK-19 ERVK-11 SOD1	3.16e-03	891	108	12	GO:0008270
GeneOntologyMolecularFunction	adenylate cyclase binding	CHRNA7 CAP1	3.31e-03	16	108	2	GO:0008179
GeneOntologyMolecularFunction	phosphoprotein binding	SRC YES1 FGR HCK	3.76e-03	117	108	4	GO:0051219
GeneOntologyMolecularFunction	DNA helicase activity	DDX12P DDX11 DDX11L8	4.62e-03	62	108	3	GO:0003678
GeneOntologyMolecularFunction	pyrophosphatase activity	PRUNE2 DDX19B DDX12P RNF213 DDX11 ARHGAP5 HSPA1L HSPA2 ATP2B2 HSPA7 DDX11L8	5.72e-03	839	108	11	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	PRUNE2 DDX19B DDX12P RNF213 DDX11 ARHGAP5 HSPA1L HSPA2 ATP2B2 HSPA7 DDX11L8	5.77e-03	840	108	11	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	PRUNE2 DDX19B DDX12P RNF213 DDX11 ARHGAP5 HSPA1L HSPA2 ATP2B2 HSPA7 DDX11L8	5.77e-03	840	108	11	GO:0016818
GeneOntologyMolecularFunction	hexosyltransferase activity	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.81e-03	211	108	5	GO:0016758
GeneOntologyMolecularFunction	ATP-dependent activity	DDX19B DDX12P RNF213 DDX11 HSPA1L HSPA2 ATP2B2 HSPA7 DDX11L8	6.10e-03	614	108	9	GO:0140657
GeneOntologyMolecularFunction	protein phosphorylated amino acid binding	YES1 FGR HCK	6.22e-03	69	108	3	GO:0045309
GeneOntologyMolecularFunction	nitric-oxide synthase binding	ARG2 NOS3	6.24e-03	22	108	2	GO:0050998
GeneOntologyBiologicalProcess	biphenyl catabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.08e-10	8	109	5	GO:0070980
GeneOntologyBiologicalProcess	biphenyl metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.27e-10	10	109	5	GO:0018879
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.89e-09	12	109	5	GO:0052697
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	4.68e-09	13	109	5	GO:0015074
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.15e-08	21	109	5	GO:0052695
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.26e-07	26	109	5	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.26e-07	26	109	5	GO:0006063
GeneOntologyBiologicalProcess	benzene-containing compound metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.43e-06	37	109	5	GO:0042537
GeneOntologyBiologicalProcess	xenobiotic catabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.43e-06	37	109	5	GO:0042178
GeneOntologyBiologicalProcess	androgen metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.64e-06	38	109	5	GO:0008209
GeneOntologyBiologicalProcess	RNA-templated DNA biosynthetic process	ERVK-6 SRC ERVK-7 ERVK-10 ERVK-8 ERVK-11	5.14e-06	83	109	6	GO:0006278
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	5.37e-06	48	109	5	GO:0000731
GeneOntologyBiologicalProcess	estrogen metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.01e-06	52	109	5	GO:0008210
GeneOntologyBiologicalProcess	immune response-regulating cell surface receptor signaling pathway involved in phagocytosis	SRC YES1 FGR HCK	8.57e-06	25	109	4	GO:0002433
GeneOntologyBiologicalProcess	Fc-gamma receptor signaling pathway involved in phagocytosis	SRC YES1 FGR HCK	8.57e-06	25	109	4	GO:0038096
GeneOntologyBiologicalProcess	peptidyl-tyrosine phosphorylation	IL24 FLT1 SRC PKDCC PTPN22 YES1 BLK FCER1A FGR HCK	9.31e-06	327	109	10	GO:0018108
GeneOntologyBiologicalProcess	peptidyl-tyrosine modification	IL24 FLT1 SRC PKDCC PTPN22 YES1 BLK FCER1A FGR HCK	9.82e-06	329	109	10	GO:0018212
GeneOntologyBiologicalProcess	regulation of inflammatory response to antigenic stimulus	SRC YES1 FCER1A FGR HCK	1.77e-05	61	109	5	GO:0002861
GeneOntologyBiologicalProcess	Fc receptor signaling pathway	SRC YES1 FCER1A FGR HCK	1.91e-05	62	109	5	GO:0038093
GeneOntologyBiologicalProcess	immune response-regulating signaling pathway	LILRA1 BTNL8 SRC PTPN22 ALPK1 YES1 BLK FCER1A SMPDL3B SLC15A2 BTN1A1 FGR HCK	2.20e-05	615	109	13	GO:0002764
GeneOntologyBiologicalProcess	establishment of sister chromatid cohesion	DDX12P DDX11 DDX11L8	2.30e-05	11	109	3	GO:0034085
GeneOntologyBiologicalProcess	Fc receptor mediated stimulatory signaling pathway	SRC YES1 FGR HCK	3.41e-05	35	109	4	GO:0002431
GeneOntologyBiologicalProcess	DNA replication	ERVK-6 DDX12P ERVK-7 ERVK-10 DDX11 UCHL5 ERVK-8 ERVK-11 DDX11L8	4.19e-05	312	109	9	GO:0006260
GeneOntologyBiologicalProcess	negative regulation of inflammatory response to antigenic stimulus	SRC YES1 FGR HCK	4.26e-05	37	109	4	GO:0002862
GeneOntologyBiologicalProcess	Fc-gamma receptor signaling pathway	SRC YES1 FGR HCK	5.26e-05	39	109	4	GO:0038094
GeneOntologyBiologicalProcess	regulation of response to external stimulus	APOBEC3D DSCAM SRC PTPN22 ALPK1 DYSF YES1 F3 CHRNA7 ARG2 FCER1A SMPDL3B SLC15A2 ROBO2 FGR NOS3 HCK SOD1 NLRP13	5.59e-05	1316	109	19	GO:0032101
GeneOntologyBiologicalProcess	xenobiotic metabolic process	AOC2 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.04e-04	141	109	6	GO:0006805
GeneOntologyBiologicalProcess	immune response-activating signaling pathway	BTNL8 SRC PTPN22 ALPK1 YES1 BLK SMPDL3B SLC15A2 BTN1A1 FGR HCK	1.67e-04	553	109	11	GO:0002757
GeneOntologyBiologicalProcess	inflammatory response to antigenic stimulus	SRC YES1 FCER1A FGR HCK	2.18e-04	103	109	5	GO:0002437
GeneOntologyBiologicalProcess	immune response-regulating cell surface receptor signaling pathway	BTNL8 SRC PTPN22 YES1 BLK FCER1A BTN1A1 FGR HCK	2.41e-04	393	109	9	GO:0002768
GeneOntologyBiologicalProcess	modification of postsynaptic actin cytoskeleton	ITSN1 DIP2A CAP1	2.68e-04	24	109	3	GO:0098885
GeneOntologyBiologicalProcess	negative regulation of inflammatory response	SRC YES1 CHRNA7 SMPDL3B FGR HCK SOD1	2.81e-04	239	109	7	GO:0050728
GeneOntologyBiologicalProcess	negative regulation of response to external stimulus	SRC YES1 CHRNA7 ARG2 SMPDL3B ROBO2 FGR NOS3 HCK SOD1	3.68e-04	509	109	10	GO:0032102
GeneOntologyBiologicalProcess	DNA-templated DNA replication	ERVK-6 ERVK-7 ERVK-10 DDX11 ERVK-8 ERVK-11	3.69e-04	178	109	6	GO:0006261
GeneOntologyBiologicalProcess	sister chromatid cohesion	DDX12P DDX11 BUB1 DDX11L8	4.38e-04	67	109	4	GO:0007062
GeneOntologyBiologicalProcess	activation of immune response	BTNL8 SRC PTPN22 ALPK1 YES1 BLK SMPDL3B SLC15A2 BTN1A1 FGR HCK	4.61e-04	623	109	11	GO:0002253
GeneOntologyBiologicalProcess	response to xenobiotic stimulus	CYBB AOC2 SRC CHRNA7 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 SOD1	4.69e-04	525	109	10	GO:0009410
GeneOntologyBiologicalProcess	protein refolding	HSPA1L HSPA2 HSPA7	5.25e-04	30	109	3	GO:0042026
GeneOntologyBiologicalProcess	regulation of caveolin-mediated endocytosis	ITSN1 SRC	5.71e-04	7	109	2	GO:2001286
GeneOntologyBiologicalProcess	negative regulation of defense response	SRC YES1 CHRNA7 ARG2 SMPDL3B FGR HCK SOD1	5.76e-04	353	109	8	GO:0031348
GeneOntologyBiologicalProcess	immune response-activating cell surface receptor signaling pathway	BTNL8 SRC PTPN22 YES1 BLK BTN1A1 FGR HCK	6.43e-04	359	109	8	GO:0002429
GeneOntologyBiologicalProcess	DNA recombination	ERVK-6 ERVK-7 ERVK-10 EZH2 KLHDC3 UCHL5 ERVK-8 ERVK-11	7.56e-04	368	109	8	GO:0006310
GeneOntologyBiologicalProcess	positive regulation of platelet-derived growth factor receptor signaling pathway	SRC F3	7.59e-04	8	109	2	GO:0010641
GeneOntologyCellularComponent	nuclear outer membrane	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.91e-06	40	108	5	GO:0005640
GeneOntologyCellularComponent	Ctf18 RFC-like complex	DDX12P DDX11 DDX11L8	1.57e-05	10	108	3	GO:0031390
GeneOntologyCellularComponent	cell-substrate junction	FLT1 SRC YES1 SHROOM4 HMCN1 TLE2 PEAK1 ALKBH6 HCK CAP1	1.00e-04	443	108	10	GO:0030055
GeneOntologyCellularComponent	focal adhesion	FLT1 SRC YES1 SHROOM4 TLE2 PEAK1 ALKBH6 HCK CAP1	4.00e-04	431	108	9	GO:0005925
GeneOntologyCellularComponent	side of membrane	LILRA1 BTNL8 AZGP1 PTPN22 F3 CHRNA7 SHROOM4 LIFR FCER1A SMPDL3B FRMD6 BTN1A1 HCK	5.79e-04	875	108	13	GO:0098552
MousePheno	increased allantois apoptosis	DDX12P DDX11 DDX11L8	8.48e-06	8	76	3	MP:0003891
MousePheno	absent paraxial mesoderm	DDX12P DDX11 DDX11L8	1.27e-05	9	76	3	MP:0012184
MousePheno	decreased paraxial mesoderm size	DDX12P DDX11 DDX11L8	3.28e-05	12	76	3	MP:0012183
MousePheno	decreased inner cell mass proliferation	DDX12P AHCTF1 EZH2 DDX11 DDX11L8	3.56e-05	69	76	5	MP:0012113
MousePheno	abnormal inner cell mass proliferation	DDX12P AHCTF1 EZH2 DDX11 DDX11L8	4.68e-05	73	76	5	MP:0004966
MousePheno	small allantois	DDX12P DDX11 DDX11L8	8.22e-05	16	76	3	MP:0004559
Domain	UDPGT	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.35e-08	21	102	5	PF00201
Domain	UDPGT	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.35e-08	21	102	5	PS00375
Domain	UDP_glucos_trans	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.35e-08	21	102	5	IPR002213
Domain	PROTEIN_KINASE_TYR	FLT1 SRC YES1 BLK PEAK1 FGR HCK	1.01e-06	97	102	7	PS00109
Domain	Tyr_kinase_AS	FLT1 SRC YES1 BLK PEAK1 FGR HCK	1.01e-06	97	102	7	IPR008266
Domain	Pkinase_Tyr	FLT1 SRC YES1 BLK LIMK2 FGR HCK	6.82e-06	129	102	7	PF07714
Domain	PROTEIN_KINASE_ATP	FLT1 SRC PKDCC SNRK YES1 BLK STK3 LIMK2 BUB1 PEAK1 FGR HCK	7.68e-06	459	102	12	PS00107
Domain	Kinase-like_dom	FLT1 SRC PKDCC SNRK ALPK1 YES1 BLK STK3 LIMK2 BUB1 PEAK1 FGR HCK	7.92e-06	542	102	13	IPR011009
Domain	TyrKc	FLT1 SRC YES1 BLK FGR HCK	8.63e-06	88	102	6	SM00219
Domain	Tyr_kinase_cat_dom	FLT1 SRC YES1 BLK FGR HCK	8.63e-06	88	102	6	IPR020635
Domain	Ser-Thr/Tyr_kinase_cat_dom	FLT1 SRC YES1 BLK LIMK2 FGR HCK	1.06e-05	138	102	7	IPR001245
Domain	Prot_kinase_dom	FLT1 SRC PKDCC SNRK YES1 BLK STK3 LIMK2 BUB1 PEAK1 FGR HCK	1.45e-05	489	102	12	IPR000719
Domain	-	LILRA1 FLT1 DSCAM BTNL8 AZGP1 F3 PTPRT LIFR FCER1A HMCN1 BTN1A1 ROBO2 MYBPC1 MYBPC3	1.46e-05	663	102	14	2.60.40.10
Domain	IG_LIKE	LILRA1 FLT1 DSCAM BTNL8 AZGP1 PTPRT FCER1A HMCN1 BTN1A1 ROBO2 MYBPC1 MYBPC3	1.51e-05	491	102	12	PS50835
Domain	PROTEIN_KINASE_DOM	FLT1 SRC PKDCC SNRK YES1 BLK STK3 LIMK2 BUB1 PEAK1 FGR HCK	1.57e-05	493	102	12	PS50011
Domain	IG	LILRA1 FLT1 DSCAM BTNL8 PTPRT FCER1A HMCN1 BTN1A1 ROBO2 MYBPC1 MYBPC3	1.90e-05	421	102	11	SM00409
Domain	Ig_sub	LILRA1 FLT1 DSCAM BTNL8 PTPRT FCER1A HMCN1 BTN1A1 ROBO2 MYBPC1 MYBPC3	1.90e-05	421	102	11	IPR003599
Domain	Ig-like_dom	LILRA1 FLT1 DSCAM BTNL8 AZGP1 PTPRT FCER1A HMCN1 BTN1A1 ROBO2 MYBPC1 MYBPC3	1.91e-05	503	102	12	IPR007110
Domain	Ig-like_fold	LILRA1 FLT1 DSCAM BTNL8 AZGP1 F3 PTPRT LIFR FCER1A HMCN1 BTN1A1 ROBO2 MYBPC1 MYBPC3	2.93e-05	706	102	14	IPR013783
Domain	FGR	YES1 FGR	2.95e-05	2	102	2	IPR028459
Domain	SH3_1	ITSN1 SRC PPP1R13B YES1 BLK FGR HCK	3.25e-05	164	102	7	PF00018
Domain	Protein_kinase_ATP_BS	FLT1 SRC SNRK YES1 BLK STK3 LIMK2 BUB1 FGR HCK	4.27e-05	379	102	10	IPR017441
Domain	IGc2	LILRA1 FLT1 DSCAM FCER1A HMCN1 ROBO2 MYBPC1 MYBPC3	4.42e-05	235	102	8	SM00408
Domain	Ig_sub2	LILRA1 FLT1 DSCAM FCER1A HMCN1 ROBO2 MYBPC1 MYBPC3	4.42e-05	235	102	8	IPR003598
Domain	IGv	FLT1 DSCAM HMCN1 BTN1A1 ROBO2	5.61e-05	75	102	5	SM00406
Domain	HSP70	HSPA1L HSPA2 HSPA7	8.41e-05	16	102	3	PF00012
Domain	HSP70_2	HSPA1L HSPA2 HSPA7	1.02e-04	17	102	3	PS00329
Domain	HSP70_3	HSPA1L HSPA2 HSPA7	1.02e-04	17	102	3	PS01036
Domain	HSP70_1	HSPA1L HSPA2 HSPA7	1.02e-04	17	102	3	PS00297
Domain	Hsp_70_fam	HSPA1L HSPA2 HSPA7	1.22e-04	18	102	3	IPR013126
Domain	FN3_dom	DSCAM F3 PTPRT LIFR ROBO2 MYBPC1 MYBPC3	1.49e-04	209	102	7	IPR003961
Domain	Neural_cell_adh	HMCN1 ROBO2	1.76e-04	4	102	2	IPR009138
Domain	SH3	ITSN1 SRC PPP1R13B YES1 BLK FGR HCK	1.83e-04	216	102	7	SM00326
Domain	SH3	ITSN1 SRC PPP1R13B YES1 BLK FGR HCK	1.83e-04	216	102	7	PS50002
Domain	SH3_domain	ITSN1 SRC PPP1R13B YES1 BLK FGR HCK	2.05e-04	220	102	7	IPR001452
Domain	SH2	SRC YES1 BLK FGR HCK	2.30e-04	101	102	5	PF00017
Domain	fn3	DSCAM PTPRT LIFR ROBO2 MYBPC1 MYBPC3	2.63e-04	162	102	6	PF00041
Domain	SH2	SRC YES1 BLK FGR HCK	3.42e-04	110	102	5	SM00252
Domain	SH2	SRC YES1 BLK FGR HCK	3.57e-04	111	102	5	PS50001
Domain	SH2	SRC YES1 BLK FGR HCK	3.72e-04	112	102	5	IPR000980
Domain	-	SRC YES1 BLK FGR HCK	3.72e-04	112	102	5	3.30.505.10
Domain	FN3	DSCAM PTPRT LIFR ROBO2 MYBPC1 MYBPC3	5.34e-04	185	102	6	SM00060
Domain	Ig_I-set	FLT1 DSCAM HMCN1 ROBO2 MYBPC1 MYBPC3	6.14e-04	190	102	6	IPR013098
Domain	I-set	FLT1 DSCAM HMCN1 ROBO2 MYBPC1 MYBPC3	6.14e-04	190	102	6	PF07679
Domain	FN3	DSCAM PTPRT LIFR ROBO2 MYBPC1 MYBPC3	7.82e-04	199	102	6	PS50853
Domain	Ig_V-set	FLT1 DSCAM BTNL8 HMCN1 BTN1A1 ROBO2	7.82e-04	199	102	6	IPR013106
Domain	-	HSPA1L HSPA2	1.88e-03	12	102	2	2.60.34.10
Domain	HSP70_peptide-bd	HSPA1L HSPA2	1.88e-03	12	102	2	IPR029047
Domain	Kelch_2	KLHDC3 FBXO42	2.22e-03	13	102	2	IPR011498
Domain	-	HSPA1L HSPA2	2.22e-03	13	102	2	1.20.1270.10
Domain	Heat_shock_70_CS	HSPA1L HSPA2	2.22e-03	13	102	2	IPR018181
Domain	HSP70_C	HSPA1L HSPA2	2.22e-03	13	102	2	IPR029048
Domain	Kelch_2	KLHDC3 FBXO42	2.22e-03	13	102	2	PF07646
Domain	PRY	BTNL8 TRIM17 BTN1A1	2.29e-03	48	102	3	SM00589
Domain	PRY	BTNL8 TRIM17 BTN1A1	2.29e-03	48	102	3	IPR006574
Domain	ig	LILRA1 FLT1 DSCAM FCER1A HMCN1	3.88e-03	190	102	5	PF00047
Domain	Immunoglobulin	LILRA1 FLT1 DSCAM FCER1A HMCN1	3.88e-03	190	102	5	IPR013151
Domain	Fd_Rdtase_FAD-bd	CYBB NOS3	4.75e-03	19	102	2	IPR017927
Domain	FAD_FR	CYBB NOS3	4.75e-03	19	102	2	PS51384
Domain	Riboflavin_synthase-like_b-brl	CYBB NOS3	4.75e-03	19	102	2	IPR017938
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT2B4 UGT2B7 UGT2B10 UGT2B28 ALDH3A2 UGT2B11	3.84e-09	25	78	6	M605
Pathway	PID_GLYPICAN_1PATHWAY	FLT1 SRC YES1 BLK FGR HCK	6.37e-09	27	78	6	M33
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 AKR1B1	8.07e-09	28	78	6	M19580
Pathway	REACTOME_PREDNISONE_ADME	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.42e-07	23	78	5	MM16639
Pathway	REACTOME_GLUCURONIDATION	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.78e-07	24	78	5	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.22e-07	25	78	5	M17787
Pathway	WP_GLUCURONIDATION	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.22e-07	25	78	5	MM15820
Pathway	WP_GLUCURONIDATION	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.74e-07	26	78	5	M39404
Pathway	PID_EPHRINB_REV_PATHWAY	SRC YES1 BLK FGR HCK	5.82e-07	30	78	5	M257
Pathway	PID_P38_ALPHA_BETA_PATHWAY	SRC YES1 BLK FGR HCK	5.82e-07	30	78	5	M76
Pathway	PID_TXA2PATHWAY	SRC YES1 BLK FGR NOS3 HCK	6.15e-07	56	78	6	M99
Pathway	PID_ALPHA_SYNUCLEIN_PATHWAY	SRC YES1 BLK FGR HCK	8.16e-07	32	78	5	M275
Pathway	PID_EPHA_FWDPATHWAY	SRC YES1 BLK FGR HCK	1.12e-06	34	78	5	M177
Pathway	REACTOME_PARACETAMOL_ADME	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.26e-06	39	78	5	MM15695
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.92e-06	41	78	5	M7399
Pathway	PID_AMB2_NEUTROPHILS_PATHWAY	SRC YES1 BLK FGR HCK	2.92e-06	41	78	5	M159
Pathway	REACTOME_ASPIRIN_ADME	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.18e-06	44	78	5	M45014
Pathway	REACTOME_ASPIRIN_ADME	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.68e-06	45	78	5	MM15694
Pathway	PID_PI3KCI_PATHWAY	SRC YES1 BLK FGR HCK	6.48e-06	48	78	5	M141
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.77e-06	51	78	5	M17726
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.66e-06	52	78	5	M14171
Pathway	PID_PTP1B_PATHWAY	SRC YES1 BLK FGR HCK	9.66e-06	52	78	5	M50
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.28e-05	55	78	5	M14933
Pathway	KEGG_RETINOL_METABOLISM	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.69e-05	64	78	5	M9488
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.16e-05	70	78	5	M16794
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.77e-05	72	78	5	M9257
Pathway	REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING	ITSN1 SRC YES1 LIMK2	8.27e-05	42	78	4	M27308
Pathway	REACTOME_FCGR_ACTIVATION	SRC YES1 FGR HCK	1.40e-04	48	78	4	MM17214
Pathway	PID_CXCR4_PATHWAY	SRC YES1 BLK FGR HCK	2.28e-04	100	78	5	M124
Pathway	WP_ANGIOGENESIS	FLT1 SRC NOS3	3.03e-04	24	78	3	M39556
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.12e-04	107	78	5	MM14595
Pathway	REACTOME_DRUG_ADME	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.40e-04	109	78	5	M45012
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.40e-04	109	78	5	M18788
Pathway	KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY	SRC CHRNA7	4.47e-04	6	78	2	M47788
Pathway	REACTOME_DRUG_ADME	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.09e-04	119	78	5	MM15692
Pathway	REACTOME_FCGR_ACTIVATION	SRC YES1 FGR HCK	5.71e-04	69	78	4	M27108
Pathway	WP_FOCAL_ADHESION	FLT1 SRC BLK ARHGAP5 FGR HCK	5.85e-04	187	78	6	MM15913
Pathway	WP_KIT_RECEPTOR_SIGNALING_PATHWAY	SRC YES1 FGR HCK	6.36e-04	71	78	4	MM15947
Pathway	REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS	SRC YES1 HCK	6.55e-04	31	78	3	M46423
Pathway	PID_PDGFRB_PATHWAY	SRC YES1 BLK FGR HCK	7.35e-04	129	78	5	M186
Pathway	WP_FOCAL_ADHESION	FLT1 SRC BLK ARHGAP5 FGR HCK	8.11e-04	199	78	6	M39402
Pathway	REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES	CYBB GPX8 SOD1	9.39e-04	35	78	3	MM14944
Pathway	REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING	ITSN1 SRC YES1	1.11e-03	37	78	3	MM15022
Pathway	REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES	CYBB GPX8 SOD1	1.11e-03	37	78	3	M27244
Pathway	REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO	SRC ROBO2	1.32e-03	10	78	2	M27348
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY	SRC CHRNA7	1.32e-03	10	78	2	M47789
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	AOC2 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.33e-03	219	78	6	MM14838
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	AOC2 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.36e-03	220	78	6	M10320
Pathway	REACTOME_EPH_EPHRIN_SIGNALING	ITSN1 SRC YES1 LIMK2	1.68e-03	92	78	4	M27201
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	SRC YES1 FGR HCK	1.89e-03	95	78	4	M29842
Pathway	REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS	BTNL8 BTN1A1	1.92e-03	12	78	2	M27738
Pathway	REACTOME_PECAM1_INTERACTIONS	SRC YES1	1.92e-03	12	78	2	MM14835
Pathway	REACTOME_PECAM1_INTERACTIONS	SRC YES1	1.92e-03	12	78	2	M11773
Pathway	WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING	SRC YES1 HCK	2.22e-03	47	78	3	M39380
Pathway	REACTOME_ATTENUATION_PHASE	HSPA1L HSPA2	2.27e-03	13	78	2	MM14952
Pathway	REACTOME_REGULATION_OF_KIT_SIGNALING	SRC YES1	2.27e-03	13	78	2	MM14565
Pathway	KEGG_CIRCADIAN_RHYTHM_MAMMAL	CRY1 PER3	2.27e-03	13	78	2	M18009
Pathway	REACTOME_SIGNALING_BY_VEGF	CYBB FLT1 SRC NOS3	2.53e-03	103	78	4	MM14752
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.32e-12	7	111	5	26074487
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.68e-11	8	111	5	32093886
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-18 ERVK-19	4.90e-10	5	111	4	12629516
Pubmed	The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome.	SRC YES1 BLK FGR HCK	5.92e-10	14	111	5	29568343
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-11	7.39e-10	94	111	8	21542922
Pubmed	Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.	SRC YES1 FGR HCK	1.47e-09	6	111	4	10861086
Pubmed	FAK-Src signalling is important to renal collecting duct morphogenesis: discovery using a hierarchical screening technique.	SRC YES1 BLK FGR HCK	3.39e-09	19	111	5	23616926
Pubmed	Proline-rich sequences that bind to Src homology 3 domains with individual specificities.	YES1 BLK FGR HCK	3.41e-09	7	111	4	7536925
Pubmed	Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis.	SRC YES1 FGR HCK	6.81e-09	8	111	4	16921024
Pubmed	Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome.	ITSN1 SRC PPP1R13B YES1 FGR HCK	2.63e-08	56	111	6	22745667
Pubmed	Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.	ITSN1 SRC YES1 BLK HCK	2.80e-08	28	111	5	18067320
Pubmed	cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.	UGT2B4 UGT2B10 UGT2B11	3.16e-08	3	111	3	8333863
Pubmed	Deficiency of the Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis.	SRC FGR HCK	3.16e-08	3	111	3	8634424
Pubmed	Loss of ChlR1 helicase in mouse causes lethality due to the accumulation of aneuploid cells generated by cohesion defects and placental malformation.	DDX12P DDX11 DDX11L8	3.16e-08	3	111	3	17611414
Pubmed	Mammalian ChlR1 has a role in heterochromatin organization.	DDX12P DDX11 DDX11L8	3.16e-08	3	111	3	21854770
Pubmed	Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.	ERVK-6 ERVK-18 ERVK-19	3.16e-08	3	111	3	10516026
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-10	1.26e-07	4	111	3	10469592
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-6 ERVK-10 ERVK-19	1.26e-07	4	111	3	7983737
Pubmed	Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells.	SRC YES1 FGR HCK	1.74e-07	16	111	4	11071635
Pubmed	The protein tyrosine kinase family of the human genome.	FLT1 SRC YES1 BLK FGR HCK	2.85e-07	83	111	6	11114734
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-10 ERVK-18 ERVK-25 ERVK-11	2.90e-07	18	111	4	18664271
Pubmed	Analysis of 5-lipoxygenase phosphorylation on molecular level by MALDI-MS.	YES1 FGR HCK	3.15e-07	5	111	3	24860872
Pubmed	Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.	FLT1 SRC YES1	3.15e-07	5	111	3	12509223
Pubmed	Palatal adhesion is dependent on Src family kinases and p38MAPK.	SRC YES1 FGR	3.15e-07	5	111	3	25354453
Pubmed	IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.	SRC FGR HCK	3.15e-07	5	111	3	21220696
Pubmed	Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma.	FLT1 SRC YES1 NOS3 HCK	5.16e-07	49	111	5	23397142
Pubmed	Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells.	SRC F3 NOS3	6.28e-07	6	111	3	17848177
Pubmed	Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2.	SRC FGR HCK	6.28e-07	6	111	3	16684964
Pubmed	Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.	SRC YES1 BLK	6.28e-07	6	111	3	2404338
Pubmed	Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1.	SRC YES1 FGR HCK	9.94e-07	24	111	4	20624904
Pubmed	Collagen, convulxin, and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets. Evidence for the involvement of Src family kinases.	SRC YES1 HCK	1.10e-06	7	111	3	10858437
Pubmed	Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress.	SRC YES1 HCK	1.10e-06	7	111	3	12538589
Pubmed	QM, a putative tumor suppressor, regulates proto-oncogene c-yes.	SRC YES1 HCK	1.10e-06	7	111	3	12138090
Pubmed	The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation.	SRC YES1 HCK	1.75e-06	8	111	3	21309750
Pubmed	The ENU-induced cetus mutation reveals an essential role of the DNA helicase DDX11 for mesoderm development during early mouse embryogenesis.	DDX12P DDX11 DDX11L8	1.75e-06	8	111	3	22678773
Pubmed	Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.	SRC YES1 FGR	1.75e-06	8	111	3	15190072
Pubmed	Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.	UGT2B4 UGT2B7 UGT2B10	1.75e-06	8	111	3	10748067
Pubmed	Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis.	SRC YES1 BLK	1.75e-06	8	111	3	31101761
Pubmed	The absence of Hck, Fgr, and Lyn tyrosine kinases augments lung innate immune responses to Pneumocystis murina.	LILRA1 FGR HCK	1.75e-06	8	111	3	19255189
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	SLC15A2 UGT2B4 UGT2B7 UGT2B28 UGT2B11	2.31e-06	66	111	5	19898482
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ITSN1 COX7C PPP1R13B DDX11 BLK FBXO42 BUB1 TNRC6A ALDH3A2 HSPA1L PRRC2B	3.03e-06	588	111	11	38580884
Pubmed	Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.	FLT1 SRC F3 F8 STK3 BUB1 HSPA1L NOS3 HCK	3.15e-06	371	111	9	25241761
Pubmed	Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes.	SRC YES1 HCK	3.74e-06	10	111	3	18155796
Pubmed	Expression of tyrosine kinase gene in mouse thymic stromal cells.	BLK FGR HCK	3.74e-06	10	111	3	8943574
Pubmed	Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.	SRC FGR HCK	3.74e-06	10	111	3	12244095
Pubmed	Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome.	SRC YES1 BLK FGR HCK	3.82e-06	73	111	5	24728074
Pubmed	Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.	SRC YES1 BLK FGR HCK	4.98e-06	77	111	5	22973453
Pubmed	Flt1/VEGFR1 heterozygosity causes transient embryonic edema.	FLT1 SRC PPP1R13B	5.12e-06	11	111	3	27251772
Pubmed	HSP90 Shapes the Consequences of Human Genetic Variation.	SRC DDX11 PER3 SOD1	5.35e-06	36	111	4	28215707
Pubmed	Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.	CYBB SRC YES1 FGR NOS3 HCK	6.37e-06	141	111	6	20056178
Pubmed	Mac-1 signaling via Src-family and Syk kinases results in elastase-dependent thrombohemorrhagic vasculopathy.	CYBB FGR HCK	6.82e-06	12	111	3	16872848
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-8 ERVK-19	6.82e-06	12	111	3	14557543
Pubmed	Dysregulation of hypoxia-inducible factor-1α (Hif1α) expression in the Hmox1-deficient placenta.	FLT1 NOS3 SOD1	8.84e-06	13	111	3	32784053
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	DDX19B ITSN1 PPP1R13B LIFR HMCN1 HSPA1L	9.79e-06	152	111	6	34299191
Pubmed	Mitochondrial arginase II constrains endothelial NOS-3 activity.	ARG2 NOS3	1.01e-05	2	111	2	17827260
Pubmed	Altered brain arginine metabolism in schizophrenia.	ARG2 NOS3	1.01e-05	2	111	2	27529679
Pubmed	A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.	MYBPC1 MYBPC3	1.01e-05	2	111	2	12628722
Pubmed	Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate.	UGT2B4 UGT2B7	1.01e-05	2	111	2	10222050
Pubmed	Isolation of duplicated human c-src genes located on chromosomes 1 and 20.	SRC FGR	1.01e-05	2	111	2	2581127
Pubmed	Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction.	FLT1 NOS3	1.01e-05	2	111	2	28115513
Pubmed	eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.	FLT1 NOS3	1.01e-05	2	111	2	22282588
Pubmed	Role of arginase-2 and eNOS in the differential vascular reactivity and hypoxia-induced endothelial response in umbilical arteries and veins.	ARG2 NOS3	1.01e-05	2	111	2	22391327
Pubmed	Prostanoid-mediated contractions of the carotid artery become Nox2-independent with aging.	CYBB NOS3	1.01e-05	2	111	2	26228838
Pubmed	Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury.	CYBB NOS3	1.01e-05	2	111	2	25326583
Pubmed	Microexon-based regulation of ITSN1 and Src SH3 domains specificity relies on introduction of charged amino acids into the interaction interface.	ITSN1 SRC	1.01e-05	2	111	2	20659428
Pubmed	Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity.	FGR HCK	1.01e-05	2	111	2	8125254
Pubmed	Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck/Fgr deficient macrophages.	FGR HCK	1.01e-05	2	111	2	10547366
Pubmed	Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.	UGT2B4 UGT2B7	1.01e-05	2	111	2	17263731
Pubmed	Isolation and functional analysis of a human 70,000-dalton heat shock protein gene segment.	HSPA1L HSPA7	1.01e-05	2	111	2	3927293
Pubmed	The Src-Family Kinases Hck and Fgr Regulate Early Lipopolysaccharide-Induced Myeloid Cell Recruitment into the Lung and Their Ability To Secrete Chemokines.	FGR HCK	1.01e-05	2	111	2	26232427
Pubmed	Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training.	SRC NOS3	1.01e-05	2	111	2	12595302
Pubmed	Ouabain stimulates a Na+/K+-ATPase-mediated SFK-activated signalling pathway that regulates tight junction function in the mouse blastocyst.	SRC YES1	1.01e-05	2	111	2	21901128
Pubmed	Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.	SRC YES1	1.01e-05	2	111	2	7507074
Pubmed	Hemopoietic Cell Kinase amplification with Protein Tyrosine Phosphatase Receptor T depletion leads to polycythemia, aberrant marrow erythoid maturation, and splenomegaly.	PTPRT HCK	1.01e-05	2	111	2	31065022
Pubmed	Deficiency of Src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions.	FGR HCK	1.01e-05	2	111	2	8666673
Pubmed	Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.	F3 F8	1.01e-05	2	111	2	25665657
Pubmed	Endothelial eNOS/arginase imbalance contributes to vascular dysfunction in IUGR umbilical and placental vessels.	ARG2 NOS3	1.01e-05	2	111	2	23122700
Pubmed	Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice.	ARG2 NOS3	1.01e-05	2	111	2	22854495
Pubmed	Maternal hypercholesterolemia in pregnancy associates with umbilical vein endothelial dysfunction: role of endothelial nitric oxide synthase and arginase II.	ARG2 NOS3	1.01e-05	2	111	2	23950140
Pubmed	Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase.	CYBB NOS3	1.01e-05	2	111	2	19934023
Pubmed	Localization of chi1-related helicase genes to human chromosome regions 12p11 and 12p13: similarity between parts of these genes and conserved human telomeric-associated DNA.	DDX12P DDX11	1.01e-05	2	111	2	8833153
Pubmed	Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population.	UGT2B4 UGT2B7	1.01e-05	2	111	2	15319348
Pubmed	The role and mechanism of asymmetric dimethylarginine in fetal growth restriction via interference with endothelial function and angiogenesis.	FLT1 NOS3	1.01e-05	2	111	2	32215825
Pubmed	Polymorphisms in genes coding for HSP-70 are associated with gastric cancer and duodenal ulcer in a population at high risk of gastric cancer in Costa Rica.	HSPA1L HSPA2	1.01e-05	2	111	2	24051039
Pubmed	Functional roles of Src and Fgr in ovarian carcinoma.	SRC FGR	1.01e-05	2	111	2	21300758
Pubmed	Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism.	ARG2 NOS3	1.01e-05	2	111	2	23760286
Pubmed	Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet.	F3 NOS3	1.01e-05	2	111	2	20626618
Pubmed	c-Abl and Src-family kinases cross-talk in regulation of myeloid cell migration.	FGR HCK	1.01e-05	2	111	2	19903482
Pubmed	Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck.	FGR HCK	1.01e-05	2	111	2	9916742
Pubmed	Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91(phox).	CYBB NOS3	1.01e-05	2	111	2	12417549
Pubmed	Elevated c-Src and c-Yes expression in malignant skin cancers.	SRC YES1	1.01e-05	2	111	2	20796316
Pubmed	Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria.	CYBB SOD1	1.01e-05	2	111	2	24586264
Pubmed	Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.	ERVK-6 ERVK-19	1.01e-05	2	111	2	9060628
Pubmed	Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.	ERVK-6 ERVK-19	1.01e-05	2	111	2	9460924
Pubmed	Fgr deficiency results in defective eosinophil recruitment to the lung during allergic airway inflammation.	FGR HCK	1.01e-05	2	111	2	12055264
Pubmed	Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion.	DDX12P DDX11	1.01e-05	2	111	2	32855419
Pubmed	Quantitative analysis of UGT2B28 mRNA expression by real-time RT-PCR and application to human tissue distribution study.	UGT2B28 UGT2B11	1.01e-05	2	111	2	21679149
Pubmed	Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.	SRC HCK	1.01e-05	2	111	2	18042718
Pubmed	The Src family kinases Hck and Fgr regulate neutrophil responses to N-formyl-methionyl-leucyl-phenylalanine.	FGR HCK	1.01e-05	2	111	2	17339487
Pubmed	The Src family kinases Hck and Fgr are dispensable for inside-out, chemoattractant-induced signaling regulating beta 2 integrin affinity and valency in neutrophils, but are required for beta 2 integrin-mediated outside-in signaling involved in sustained adhesion.	FGR HCK	1.01e-05	2	111	2	16785558
Interaction	UGT2B28 interactions	UGT2B10 UGT2B28 UGT2B11	2.80e-06	6	106	3	int:UGT2B28
Interaction	TRPV4 interactions	SRC YES1 OS9 HCK	4.92e-06	22	106	4	int:TRPV4
Interaction	SKAP2 interactions	SRC YES1 BLK FGR HCK	7.09e-06	51	106	5	int:SKAP2
Interaction	PXN interactions	SRC YES1 BLK ARHGAP5 LIMK2 TNRC6A PEAK1 HSPA7 HCK CAP1	1.07e-05	334	106	10	int:PXN
Interaction	CBL interactions	FLT1 ITSN1 SRC PTPN22 EZH2 YES1 BLK FGR ALDH3A2 HSPA1L HSPA2 HCK	1.73e-05	516	106	12	int:CBL
Interaction	ANKRD54 interactions	ITSN1 SRC YES1 BLK	2.63e-05	33	106	4	int:ANKRD54
Interaction	KHDRBS1 interactions	DSCAM ITSN1 SRC PPP1R13B NCKAP5 EZH2 YES1 CRY1 FGR HCK	2.75e-05	373	106	10	int:KHDRBS1
Interaction	AIP interactions	APOBEC3D SRC YES1 BLK LIMK2 TLE2 FGR	5.01e-05	182	106	7	int:AIP
Interaction	KIT interactions	FLT1 SRC YES1 BLK FGR HCK	5.19e-05	125	106	6	int:KIT
Interaction	ZNF2 interactions	APOBEC3D ZNF184 RRP8 RBM19 UTP3	6.43e-05	80	106	5	int:ZNF2
Interaction	AFDN interactions	DSCAM SRC PPP1R13B YES1 FRMD6 KLHDC3 TNRC6A PEAK1 HSPA2	6.64e-05	333	106	9	int:AFDN
Interaction	SLC31A1 interactions	ZNF268 SNRK DDX11 DIP2A LIMK2 KLHDC3 PEAK1	7.03e-05	192	106	7	int:SLC31A1
Interaction	RNF43 interactions	AHCTF1 ITSN1 PPP1R13B STK3 TNRC6A PEAK1 ALDH3A2 HSPA1L HSPA2 PRRC2B	8.54e-05	427	106	10	int:RNF43
Cytoband	Ensembl 112 genes in cytogenetic band chr4q13	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UTP3 UGT2B11	2.32e-06	157	110	6	chr4q13
Cytoband	20q12-q13	SRC PTPRT	5.69e-06	2	110	2	20q12-q13
Cytoband	4q13.2	UGT2B10 UGT2B28 UGT2B11	5.73e-05	31	110	3	4q13.2
Cytoband	4q13	UGT2B4 UGT2B7	5.85e-04	15	110	2	4q13
GeneFamily	UDP glucuronosyltransferases	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.61e-07	32	72	5	363
GeneFamily	Heat shock 70kDa proteins	HSPA1L HSPA2 HSPA7	3.96e-05	17	72	3	583
GeneFamily	Fibronectin type III domain containing	DSCAM PTPRT LIFR ROBO2 MYBPC1 MYBPC3	4.22e-05	160	72	6	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT1 DSCAM HMCN1 ROBO2 MYBPC1 MYBPC3	4.37e-05	161	72	6	593
GeneFamily	SH2 domain containing	SRC YES1 BLK FGR HCK	5.12e-05	101	72	5	741
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYBPC1 MYBPC3	4.31e-04	8	72	2	658
GeneFamily	DEAD-box helicases	DDX19B DDX12P DDX11	6.22e-04	42	72	3	499
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTNL8 BTN1A1	1.59e-03	15	72	2	458
GeneFamily	Nucleoporins	DDX19B AHCTF1	7.18e-03	32	72	2	1051
GeneFamily	Immunoglobulin like domain containing	FLT1 DSCAM PTPRT FCER1A	7.36e-03	193	72	4	594
Coexpression	GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN	ITSN1 PPP1R13B RNF213 PCYOX1L SMPDL3B PER3 HSPA2 CAP1	1.28e-06	200	103	8	M6187
Coexpression	WENG_POR_TARGETS_LIVER_UP	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.10e-06	53	103	5	MM1203
Coexpression	AIZARANI_LIVER_C20_LSECS_3	FLT1 AHCTF1 SNRK YES1 F8 SHROOM4 LIFR PEAK1 NOS3	2.55e-06	295	103	9	M39121
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_708_5P_GENES	DDX12P SNRK DDX11 DDX11L8	4.16e-05	49	103	4	MM17508
Coexpression	PILON_KLF1_TARGETS_UP	FLT1 ITSN1 PKDCC PER3 BTN1A1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.47e-05	541	103	10	MM1061
Coexpression	VANLOO_SP3_TARGETS_DN	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.48e-05	103	103	5	MM919
Coexpression	VANTVEER_BREAST_CANCER_METASTASIS_DN	FLT1 EZH2 STK3 UCHL5 BUB1	7.18e-05	109	103	5	M9826
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	NCKAP5 PLEKHA6 DYSF LIFR TLE2 BTN1A1	8.97e-05	184	103	6	M8544
Coexpression	AIZARANI_LIVER_C10_MVECS_1	FLT1 SNRK DYSF F8 SHROOM4 LIFR NOS3	9.50e-05	269	103	7	M39114
Coexpression	BOCHKIS_FOXA2_TARGETS	PLEKHA6 LIFR UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 ALKBH6 HSPA1L	9.57e-05	467	103	9	MM1233
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	NCKAP5 PLEKHA6 DYSF LIFR TLE2 BTN1A1	1.01e-04	188	103	6	MM983
Coexpression	DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS	FLT1 PPP1R13B SNRK DYSF YES1 PEAK1 NOS3	1.02e-04	272	103	7	MM3634
Coexpression	SERVITJA_LIVER_HNF1A_TARGETS_DN	LIFR UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.07e-04	190	103	6	MM1311
Coexpression	SERVITJA_ISLET_HNF1A_TARGETS_DN	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.18e-04	121	103	5	MM935
Coexpression	GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP	PLEKHA6 ARHGAP5 FCER1A SLC15A2 TLE2 FBXO42	1.34e-04	198	103	6	M4539
Coexpression	GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP	RNF213 NCKAP5 YES1 CA10 SHROOM4 UGT2B10	1.42e-04	200	103	6	M7903
Coexpression	GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN	PRUNE2 ZNF268 AHCTF1 RRP8 DYSF SOD1	1.42e-04	200	103	6	M7240
Coexpression	GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN	CYBB DDX19B ITSN1 SNRK F3 OS9	1.42e-04	200	103	6	M5758
Coexpression	GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN	CYBB SRC RBM19 FBXO42 OS9 HCK	1.42e-04	200	103	6	M8682
Coexpression	OHGUCHI_LIVER_HNF4A_TARGETS_DN	LIFR UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.46e-04	201	103	6	MM1294
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 SNRK NCKAP5 DYSF SHROOM4 LIFR HMCN1 ROBO2	1.73e-08	194	103	8	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 YES1 SHROOM4 LIFR ARHGAP5 HMCN1 NOS3	2.61e-07	186	103	7	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 PPP1R13B SNRK NCKAP5 YES1 LIFR HMCN1	3.24e-07	192	103	7	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 SNRK NCKAP5 DYSF SHROOM4 LIFR HMCN1	3.35e-07	193	103	7	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 NCKAP5 DYSF YES1 SHROOM4 LIFR HMCN1	3.35e-07	193	103	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	GPX8 AOC2 LIFR FRMD6 TRIM17 PNMA2 ROBO2	3.47e-07	194	103	7	811b382ec3da06a6bda7360abc8b633f96b2019e
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT1 BTNL8 SNRK DYSF F8 SHROOM4 LIFR	3.72e-07	196	103	7	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	FLT1 BTNL8 SNRK DYSF F8 SHROOM4 LIFR	3.85e-07	197	103	7	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLT1 BTNL8 MUC12 DYSF F8 NOS3 MYBPC1	4.12e-07	199	103	7	079931e7196719f22a89cfad82f452ec67219ee5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 BTNL8 DYSF FGR NOS3 MYBPC1	1.65e-06	155	103	6	59035d792c26d870a8b097939e97fa47859ba68c
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	CYBB LILRA1 FCER1A PNMA2 HCK MYBPC3	4.04e-06	181	103	6	921e917f83105896ad8918dc134b871708024021
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FLT1 YES1 SHROOM4 HMCN1 TLE2 NOS3	4.17e-06	182	103	6	997d37ca2af661c92a56add888762724dfccc890
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 DYSF YES1 STK3 SHROOM4 LIMK2	4.44e-06	184	103	6	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBB LILRA1 FCER1A FGR AKR1B1 HCK	4.87e-06	187	103	6	8e1d6d25db5b5c91a651bb2d66edfcf073a31704
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	PRUNE2 PPP1R13B NCKAP5 DYSF ROBO2 MYBPC3	5.02e-06	188	103	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 BTNL8 DYSF F8 SHROOM4 LIFR	5.02e-06	188	103	6	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CYBB LILRA1 PTPN22 FCER1A FGR HCK	5.17e-06	189	103	6	911bedfda2ae032bc8f18ee408d16926cda8ccc2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB LILRA1 DYSF F3 FGR HCK	5.50e-06	191	103	6	9f0d956e9a14b1cd2c20a52639c6b22c349b377e
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 PPP1R13B DYSF SHROOM4 HMCN1 NOS3	5.66e-06	192	103	6	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 SNRK F8 LIFR PEAK1 NOS3	5.66e-06	192	103	6	2bfac6b3956265205ca47d06888851ed68b65999
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 SNRK F8 LIFR PEAK1 NOS3	5.66e-06	192	103	6	d525f7f088a53110912600a7c9f6d33b9270d534
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 BTNL8 DYSF F8 SHROOM4 LIFR	6.01e-06	194	103	6	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 DSCAM BTNL8 DYSF F8 PEAK1	6.01e-06	194	103	6	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLT1 GPX8 DYSF SHROOM4 HMCN1 NOS3	6.19e-06	195	103	6	4658fb197657d7692ee344ae76b11b0210c418ba
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 SNRK YES1 SHROOM4 LIMK2 NOS3	6.19e-06	195	103	6	818bc18c5834238e5f733cac6fe928ed0788f57d
ToppCell	facs-Aorta-Heart-3m-Endothelial\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 SNRK DYSF F8 LIFR NOS3	6.19e-06	195	103	6	8493f2f60fc356af28b9c0e287d4cd8c8899c081
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB LILRA1 FLT1 SRC FGR HCK	6.19e-06	195	103	6	9168267a799bbd4111b1227754ab8173ac1a4714
ToppCell	facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 SNRK DYSF F8 LIFR NOS3	6.19e-06	195	103	6	5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	FLT1 F8 PTPRT SHROOM4 LIFR ROBO2	6.37e-06	196	103	6	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 DYSF F8 SHROOM4 LIMK2 NOS3	6.37e-06	196	103	6	4cd1e6b7a791e11a40b19f971b7011bd11fe6273
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 DYSF F8 SHROOM4 LIMK2 NOS3	6.37e-06	196	103	6	d37f714d4fb57e958f3738fdda085560813e5bb5
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FLT1 BTNL8 DYSF F8 SHROOM4 LIFR	6.75e-06	198	103	6	2400f8b8c51739ea2ae2b9f24f44eaeefa2bb6fc
ToppCell	(6)_Endothelial-E\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	FLT1 BTNL8 DYSF F8 SHROOM4 LIFR	6.75e-06	198	103	6	a5e1b321376caf262ea48904d31afd1b8e9d3be2
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLT1 BTNL8 SNRK DYSF F8 NOS3	6.95e-06	199	103	6	d58edc5f74970bb26d844746184e4bae7c494d6b
ToppCell	Control-Control-Myeloid-Neutrophil\|Control / Disease, condition lineage and cell class	BTNL8 AHCTF1 AOC2 ALPK1 DYSF LIMK2	7.15e-06	200	103	6	95c41f147a1594d49e73cb56d86d301c3115ce20
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLT1 RNF213 SNRK NCKAP5 LIFR HMCN1	7.15e-06	200	103	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF502 ZNF184 F8 PER3 MYBPC1	2.06e-05	143	103	5	57ee1830d96d73d92b5f83b028592a5d952c6013
ToppCell	PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CYBB PTPN22 SMPDL3B FGR HCK	3.13e-05	156	103	5	166f7b1220eaf8e1149dde260dd85a094855c54f
ToppCell	PND07-28-samps-Myeloid-Granulocyte\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CYBB PTPN22 SMPDL3B FGR HCK	3.13e-05	156	103	5	5e1c5a7c9293b886920739cf766521df7f69726c
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF502 ANO9 PTPN22 BUB1 TRMT13	3.53e-05	160	103	5	8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AOC2 WDR25 F8 PCYOX1L SMPDL3B	3.86e-05	163	103	5	3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell	Control-APC-like-Monocytes\|Control / group, cell type (main and fine annotations)	LILRA1 APOBEC3D AKR1B1 HCK MYBPC3	3.86e-05	163	103	5	4bc80a2c741d462724b6f3902377d48c57478932
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_C\|TCGA-Thymus / Sample_Type by Project: Shred V9	SMPDL3B UGT2B28 UGT2B11 HCK MYBPC1	3.86e-05	163	103	5	2dac87d15051151ccf193760ddd8b82534c3f922
ToppCell	Mild-MAIT\|World / Disease group and Cell class	PRUNE2 CA10 CRY1 BLK TMEM62	3.97e-05	164	103	5	21dc02997dfae73cf70ce291661928526605dba1
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM PKDCC ARHGAP5 KLHDC3 TNRC6A	4.21e-05	166	103	5	66026988509e39e41274fa0de738383219e8ff30
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB NCKAP5 F3 SMPDL3B RBM19	4.58e-05	169	103	5	15a9183c838cc6384d7f5dfeae3d30602964c9b3
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic\|GI_small-bowel / Manually curated celltypes from each tissue	CYBB LILRA1 FLT1 FGR HCK	4.85e-05	171	103	5	098a7fd387357c0d4e1a6169af4d24ef95b30018
ToppCell	facs-Thymus-Flowthrough-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB DSCAM BLK TMEM62 HCK	4.98e-05	172	103	5	356a66cd9303470e427005cc67fdd22a2c4bf971
ToppCell	facs-Thymus-Flowthrough-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB DSCAM BLK TMEM62 HCK	4.98e-05	172	103	5	46fadeee483fdf8402df92ec98575a09c6c15b16
ToppCell	metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	FCER1A SMPDL3B HCK MYBPC1 MYBPC3	4.98e-05	172	103	5	38d17e769fe8eac8b57b820490d4ddd969243ee7
ToppCell	facs-Thymus-Flowthrough-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB DSCAM BLK TMEM62 HCK	4.98e-05	172	103	5	438d2e7f1897668a14d85ca70722e5d0102606dc
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 SNRK DYSF SHROOM4 NOS3	5.12e-05	173	103	5	ad9777e4ae70b11676ec735eb6db91776ca0cb19
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_small-bowel / Manually curated celltypes from each tissue	CYBB LILRA1 FLT1 FGR HCK	5.26e-05	174	103	5	05d54a36772f096047521e16a89cc42ae48d2a1d
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LILRA1 ALPK1 F3 PCYOX1L HSPA2	5.26e-05	174	103	5	e5f12831187140e84b9a49e93b2376b9fefb1aec
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D3\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	LILRA1 ALPK1 F3 PCYOX1L HSPA2	5.56e-05	176	103	5	bd5c85b3a4fb88ffe156599f6d224aa7664a513a
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	PRUNE2 ZNF618 NCKAP5 PLEKHA6 UGT2B7	5.56e-05	176	103	5	36f77d878a53b30465b0dea8333a3865dba75613
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 EZH2 DYSF BUB1 NOS3	5.71e-05	177	103	5	73ba0f0b4b33f10e9f036d6d9befa48a1258e682
ToppCell	10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	GPX8 AOC2 LIFR TRIM17 PNMA2	5.86e-05	178	103	5	8f31b3fac51591f7f2bcb898c07708b3e9f93a16
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 F8 LIFR HMCN1 NOS3	5.86e-05	178	103	5	ebfae386a518ea33911ba3ff40464c94d18ef695
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 F8 LIFR HMCN1 NOS3	5.86e-05	178	103	5	ccd37575b60102f5e647c01546e8ff8fec638bd7
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 F8 LIFR HMCN1 NOS3	5.86e-05	178	103	5	87b04753650e45f12299c8456fb980d6c0d5961c
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	GPX8 LIFR FRMD6 TRIM17 ROBO2	5.86e-05	178	103	5	e32f5ed7a492edfa7073416008b1fcfae6b854ad
ToppCell	Bronchial_Biopsy-Immune-Neutrophils\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	CYBB LILRA1 FCER1A FGR HCK	6.02e-05	179	103	5	8c50e13927c09de05c86cd90dd6f71cee004b0d3
ToppCell	Control-Myeloid-Monocytes,_Macrophages\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB LILRA1 FCER1A FGR HCK	6.02e-05	179	103	5	a79a244bf8ecc333d034b2eb2de554d3310ca6de
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB LILRA1 FGR AKR1B1 HCK	6.02e-05	179	103	5	dc03b9045510eb1bb934329646bb92dd06890ce9
ToppCell	LPS_only-Myeloid-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB ARG2 LIMK2 FGR HCK	6.02e-05	179	103	5	d0a03e498afcfeb657037889685ecd77bed07e6c
ToppCell	Control-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB LILRA1 FCER1A FGR HCK	6.02e-05	179	103	5	c4ff8b191ed0f6dc2dd784869f6f2c62e170a7db
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB LILRA1 FGR AKR1B1 HCK	6.02e-05	179	103	5	330c1326ba93bb8f32559ee1cc40e357cc44ad8d
ToppCell	LPS_only-Myeloid-Neutrophils-Neutrophils\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB ARG2 LIMK2 FGR HCK	6.02e-05	179	103	5	d034651a5a355a58f5e15db627869f4feebdfe35
ToppCell	metastatic_Brain-Myeloid_cells-Pleural_Mac\|metastatic_Brain / Location, Cell class and cell subclass	CYBB LILRA1 FCER1A FGR HCK	6.18e-05	180	103	5	7de1c8ab1152fa517c6b4830d93ff53a19fca3d7
ToppCell	LPS-IL1RA-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB ARG2 LIMK2 FGR HCK	6.18e-05	180	103	5	c0c07937839652e01df10cc1e70aa005800ea6f6
ToppCell	LPS-IL1RA-Myeloid-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB ARG2 LIMK2 FGR HCK	6.18e-05	180	103	5	079c199425dd3c220f03c6dca1823946f07580a1
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 SNRK DYSF F8 HMCN1	6.34e-05	181	103	5	4df7972f88117108698efd06b124b232f8588981
ToppCell	PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CYBB LILRA1 PTPN22 FCER1A HCK	6.34e-05	181	103	5	f737f2b1f35747b81fdd8996e289bde5c290af61
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 YES1 SHROOM4 ARHGAP5 PEAK1	6.34e-05	181	103	5	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	Control-Myeloid\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB LILRA1 FCER1A FGR HCK	6.34e-05	181	103	5	25170e5285996cc80337d5f86a0255569861ae77
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FLT1 BTNL8 SNRK DYSF YES1	6.34e-05	181	103	5	2c660fcf0404c155955b67ab2958d6e6b0e30024
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 SNRK DYSF F8 HMCN1	6.34e-05	181	103	5	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB ARG2 LIMK2 FGR HCK	6.51e-05	182	103	5	243c783675df495ea4112dbf710712c44ea6b4f1
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	GPX8 FRMD6 TRIM17 PNMA2 ROBO2	6.51e-05	182	103	5	ba066ff9029cc052b76e2330ec168cb2e9b7e498
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT1 SNRK DYSF LIFR HMCN1	6.51e-05	182	103	5	d0e3663f7d39f22a3ebd7fde56ab3504773598f4
ToppCell	droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 YES1 SHROOM4 ARHGAP5 TRIM17	6.51e-05	182	103	5	81279877b920b5a1bc991a07d3031d6458700fe3
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 FLT1 SHROOM4 ATP2B2 NOS3	6.51e-05	182	103	5	c7f2d24697affa530b748ab32b1d40bdc1bdc20a
ToppCell	LPS_only-Myeloid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB ARG2 LIMK2 FGR HCK	6.51e-05	182	103	5	666ac86ee5f6fa9241ae8d80340743707e54b278
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 FLT1 SHROOM4 ATP2B2 NOS3	6.51e-05	182	103	5	d95635b74e8cd8bc00bfe40340806b59fb9bee43
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANO9 C1orf167 F8 LIFR HMCN1	6.51e-05	182	103	5	f231e86524b628e6e11ac33d5c34be99d454a92a
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB ARG2 LIMK2 FGR HCK	6.51e-05	182	103	5	18790a394dc32b3cef99cdbf826392c520e38b4a
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT1 SNRK DYSF LIFR BUB1	6.68e-05	183	103	5	52af3c943116073c8ddd207b664342960b88929b
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	GPX8 FRMD6 TRIM17 PNMA2 ROBO2	6.68e-05	183	103	5	27a57cd8ea924420e182f3d72f5b29b00dea8fa0
ToppCell	3'_v3-GI_small-bowel-Myeloid_Dendritic-DC2\|GI_small-bowel / Manually curated celltypes from each tissue	CYBB LILRA1 SRC FCER1A HCK	6.68e-05	183	103	5	c94ee9f35b21252e1ab5ab15b6a2ce69a7d753f7
ToppCell	PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_B\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CYBB LILRA1 PTPN22 FCER1A HCK	6.68e-05	183	103	5	ffa7f2b2929ea4bd53f3f1ae23bd27f8bb4aac47
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT1 F8 SHROOM4 LIFR NOS3	6.68e-05	183	103	5	a644258ba90acc62d571623e429d72ffc4b69203
ToppCell	Nasal_Brush-Immune-Dendritic_cells\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	CYBB LILRA1 FCER1A FGR HCK	6.68e-05	183	103	5	b1daec831990a53e846c089cebfcf4f8440820e4
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	DSCAM PKDCC NCKAP5 F3 ALDH3A2	6.86e-05	184	103	5	cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	DSCAM PKDCC NCKAP5 F3 ALDH3A2	6.86e-05	184	103	5	bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCell	mild-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	BTNL8 AHCTF1 AOC2 ALPK1 LIMK2	6.86e-05	184	103	5	1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	DSCAM NCKAP5 F3 SLC15A2 PEAK1	7.04e-05	185	103	5	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Monocytes\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBB LILRA1 FCER1A FGR HCK	7.04e-05	185	103	5	f8de11dd53b34d36368a2082f24ec1416cb7dbae
ToppCell	PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CYBB LILRA1 PTPN22 FCER1A HCK	7.04e-05	185	103	5	5ec2c3ae5c477645241e8eaf19d222562e1f7ed6
ToppCell	LPS_only\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNF213 EZH2 CRY1 ARG2 LIMK2	7.04e-05	185	103	5	a72ccb147ca505880e2da8f6a70b9d570464a691
Drug	C1 11-32	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.47e-08	18	104	5	CID000443077
Drug	C11131	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.47e-08	18	104	5	CID000443076
Drug	T4-G	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.99e-08	19	104	5	CID000152424
Drug	estriol-16-glucuronide	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.46e-08	21	104	5	CID000122281
Drug	estradiol-3-glucuronide	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.69e-08	23	104	5	CID000066651
Drug	4-hydroxy-2-nonenal	CYBB ITSN1 SRC ALPK1 YES1 F3 CRY1 STK3 ARHGAP5 BUB1 FGR AKR1B1 HSPA1L HSPA2 NOS3 HCK CAP1	1.21e-07	798	104	17	ctd:C027576
Drug	L-idaro-1,4-lactone	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.63e-07	28	104	5	CID000078997
Drug	7-hydroxycoumarin glucuronide	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.96e-07	29	104	5	CID000125641
Drug	AC1Q6OQG	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.87e-07	33	104	5	CID000009686
Drug	BP-3,6-quinol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.87e-07	33	104	5	CID000119292
Drug	AC1NOWCJ	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.25e-07	35	104	5	CID005120112
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.25e-07	35	104	5	CID010436171
Drug	estrone-3-glucuronide	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	5.25e-07	35	104	5	CID000115255
Drug	ponatinib	FLT1 SRC YES1 BLK FGR HCK	6.83e-07	68	104	6	ctd:C545373
Drug	l-borneol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.00e-07	37	104	5	CID000010049
Drug	harmol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.05e-06	40	104	5	CID000068094
Drug	testosterone glucuronide	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.19e-06	41	104	5	CID000108192
Drug	2-AF	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.19e-06	41	104	5	CID000005800
Drug	Zinc Sulfate	IL24 FLT1 SRC SNRK PTPN22 DYSF CHRNA7 DDX11 BLK FCER1A PER3 PNMA2 ROBO2 HSPA1L SOD1	1.33e-06	739	104	15	ctd:D019287
Drug	16-epiestriol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 NOS3	1.43e-06	77	104	6	CID000003269
Drug	androsterone glucuronide	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.51e-06	43	104	5	CID000114833
Drug	7,8-benzoquinoline	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.51e-06	43	104	5	CID000009191
Drug	MS-222	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.70e-06	44	104	5	CID000011400
Drug	2-hydroxyestriol	UGT2B4 UGT2B7 UGT2B10	1.83e-06	6	104	3	CID000014688
Drug	flavone glycoside	BTN1A1 UGT2B4 AKR1B1	1.83e-06	6	104	3	CID005481244
Drug	salicylamide	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.64e-06	48	104	5	CID000005147
Drug	AC1NQGK1	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.96e-06	52	104	5	CID005195977
Drug	butylated hydroxytoluene	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 AKR1B1 SOD1	4.25e-06	143	104	7	CID000031404
Drug	oxazepam	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.35e-06	53	104	5	CID000004616
Drug	VX-745	SRC YES1 FGR HCK	4.83e-06	25	104	4	CID003038525
Drug	7-methoxycoumarin	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.26e-06	57	104	5	CID000010748
Drug	phenolphthalein	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.82e-06	58	104	5	CID000004764
Drug	urochloralic acid	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.43e-06	59	104	5	CID003036914
Drug	4-hydroxybiphenyl	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.43e-06	59	104	5	CID000007103
Drug	4-hydroxyestrone	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.43e-06	59	104	5	CID000018418
Drug	acetaminophen glucuronide	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.43e-06	59	104	5	CID000083944
Drug	SN-38G	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.43e-06	59	104	5	CID000443154
Drug	UDP-alpha-d-xylopyranose	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.07e-06	60	104	5	CID000001165
Drug	disulfiram	UGT2B4 UGT2B7 UGT2B10 UGT2B28 ALDH3A2 UGT2B11 AKR1B1	8.20e-06	158	104	7	CID000003117
Drug	chrysin	YES1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.26e-06	106	104	6	CID005281607
Drug	dimethylarsinic acid	SRC F3 F8 BTN1A1 AKR1B1 NOS3	9.77e-06	107	104	6	CID000002513
Drug	3-OHBaP	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.03e-05	63	104	5	CID000025890
Drug	buthionine sulfoximine	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 AKR1B1 NOS3 SOD1	1.04e-05	229	104	8	CID000021157
Drug	estrone-d4	YES1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 NOS3	1.22e-05	168	104	7	CID000000698
Drug	zomepirac	AZGP1 UGT2B4 UGT2B7	1.49e-05	11	104	3	CID000005733
Drug	Meldola	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.50e-05	68	104	5	CID000081507
Drug	ethoxyquin	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 AKR1B1	1.55e-05	116	104	6	CID000003293
Drug	methoxyresorufin	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.61e-05	69	104	5	CID000119220
Drug	fibrates	LIFR UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.71e-05	118	104	6	CID000002797
Drug	alpha-naphthoflavone	DDX11 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.71e-05	118	104	6	CID000011790
Drug	Hydroxydimethylarsine Oxide	AKR1B1 NOS3	2.07e-05	2	104	2	DB02994
Drug	2-hydroxyestriol	UGT2B7 UGT2B11	2.07e-05	2	104	2	ctd:C008012
Drug	eugenol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.12e-05	73	104	5	CID000003314
Drug	2,2,2-trichloroethanol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.12e-05	73	104	5	CID000008259
Drug	7-hydroxycoumarin	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.42e-05	75	104	5	CID005281426
Drug	chromium	DDX19B AZGP1 SRC YES1 OS9 AKR1B1 NOS3 HCK SOD1	2.57e-05	339	104	9	CID000023976
Drug	DNCB	GPX8 ARG2 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.62e-05	189	104	7	CID000000006
Drug	uridine 5'-diphosphoglucuronic acid	DDX19B GPX8 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.62e-05	189	104	7	CID000000390
Drug	benzyloxyresorufin	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.92e-05	78	104	5	CID000114982
Drug	AC1N8H7N	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	2.92e-05	78	104	5	CID004318740
Drug	dioxin	CA10 UGT2B4 UGT2B7 UGT2B10 UGT2B28 ALDH3A2 UGT2B11 HSPA2 SOD1	3.08e-05	347	104	9	CID000015625
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; PC3; HT_HG-U133A	FLT1 LIMK2 SMPDL3B SLC15A2 TTLL1 HSPA2 MYBPC3	3.30e-05	196	104	7	7316_UP
Drug	2-butyl-6-methoxyphenol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 AKR1B1 SOD1	3.41e-05	197	104	7	CID011954184
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CYBB DSCAM WDR25 PLEKHA6 DYSF LIMK2 FBXO42	3.41e-05	197	104	7	3189_DN
Drug	acridine	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	3.51e-05	81	104	5	CID000009215
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ITSN1 ALPK1 CRY1 STK3 LIMK2 SLC15A2 HSPA2	3.64e-05	199	104	7	6006_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF268 ITSN1 ZNF184 SLC15A2 KLHDC3 TRMT13 ALDH3A2	3.64e-05	199	104	7	6923_DN
Drug	beta-naphthoflavone	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 AKR1B1 SOD1	3.76e-05	200	104	7	CID000002361
Drug	oltipraz	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 AKR1B1	3.98e-05	137	104	6	CID000047318
Drug	phenobarbital	F8 ARG2 PNMA2 UGT2B4 UGT2B7 UGT2B10 UGT2B28 ALDH3A2 UGT2B11	4.10e-05	360	104	9	CID000004763
Drug	5 alpha-androstane	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.18e-05	84	104	5	CID000094144
Drug	manganese chloride	FLT1 SRC CHRNA7 CRY1 BUB1 TNRC6A AKR1B1 ATP2B2 NOS3 SOD1	4.58e-05	456	104	10	ctd:C025340
Drug	7-ethoxycoumarin	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.69e-05	86	104	5	CID000035703
Drug	pheophytin	F3 F8 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11 NOS3	4.86e-05	284	104	8	CID000000250
Drug	menthol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.95e-05	87	104	5	CID000001254
Drug	pentoxyresorufin	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	4.95e-05	87	104	5	CID000107683
Drug	2 E1	UGT2B4 UGT2B7 UGT2B10 UGT2B28 ALDH3A2 UGT2B11	5.47e-05	145	104	6	CID006102788
Drug	4-hydroxymethylphenoxyacetic acid	F3 F8	6.18e-05	3	104	2	CID000194291
Drug	5 alpha-dihydroaldosterone	UGT2B4 UGT2B7	6.18e-05	3	104	2	CID003036614
Drug	Phosphonotyrosine	SRC HCK	6.18e-05	3	104	2	DB01962
Drug	4-aminobiphenyl	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.48e-05	92	104	5	CID000007102
Drug	p-nitroanisole	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.48e-05	92	104	5	CID000007485
Drug	2-naphthol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	6.82e-05	93	104	5	CID000008663
Drug	ethoxyresorufin	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.55e-05	95	104	5	CID000003294
Drug	DCNB	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	7.55e-05	95	104	5	CID000007443
Drug	DB04103	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.34e-05	97	104	5	CID004469987
Drug	1-naphthol	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	8.75e-05	98	104	5	CID000007005
Drug	vandetanib	FLT1 SRC YES1 FGR HCK	9.18e-05	99	104	5	CID003081361
Drug	3-methylcholanthrene	F3 UGT2B4 UGT2B7 UGT2B10 UGT2B28 ALDH3A2 UGT2B11	9.32e-05	231	104	7	CID000001674
Drug	AC1LCF1F	AZGP1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	9.76e-05	161	104	6	CID000627275
Drug	N'-nitrosoanatabine	UGT2B4 UGT2B7 UGT2B10	9.97e-05	20	104	3	CID000051291
Drug	3-hydroxyandrostan-17-one	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.06e-04	102	104	5	CID000000225
Drug	trans-3,4,5-trihydroxystilbene	ERVK-6 FLT1 SRC COX7C YES1 F3 BUB1 UGT2B7 NOS3 HCK SOD1	1.06e-04	608	104	11	CID000005056
Drug	AC1L1E6H	FLT1 HSPA2 NOS3 SOD1	1.09e-04	54	104	4	CID000002661
Drug	colterol	F3 AKR1B1	1.23e-04	4	104	2	CID000025103
Drug	malabaricone B	ARG2 NOS3	1.23e-04	4	104	2	CID000163001
Drug	(4-(4'-chloro-2'-fluoro)phenylamino)-6,7-dimethylquinazoline	FLT1 SRC	1.23e-04	4	104	2	ctd:C575425
Drug	N-DAM	AOC2 F8	1.23e-04	4	104	2	CID000152320
Drug	U 74389F	F3 NOS3	1.23e-04	4	104	2	ctd:C074965
Drug	fluconazole	UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2B11	1.33e-04	107	104	5	CID000003365
Disease	carcinoma (implicated_via_orthology)	FLT1 SRC YES1 BLK STK3 FGR HCK	1.91e-09	64	98	7	DOID:305 (implicated_via_orthology)
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	UGT2B4 UGT2B7 UGT2B10 UGT2B11	1.42e-08	9	98	4	EFO_0600040
Disease	Warsaw breakage syndrome (implicated_via_orthology)	DDX12P DDX11 DDX11L8	3.55e-08	3	98	3	DOID:0060535 (implicated_via_orthology)
Disease	colorectal cancer (implicated_via_orthology)	SRC YES1 BLK FGR HCK	4.86e-08	30	98	5	DOID:9256 (implicated_via_orthology)
Disease	intestinal cancer (implicated_via_orthology)	SRC YES1 BLK FGR HCK	6.84e-08	32	98	5	DOID:10155 (implicated_via_orthology)
Disease	kidney disease (implicated_via_orthology)	SRC YES1 BLK FGR HCK	2.48e-07	41	98	5	DOID:557 (implicated_via_orthology)
Disease	cancer (implicated_via_orthology)	FLT1 SRC YES1 BLK STK3 FRMD6 FGR HCK	3.24e-06	268	98	8	DOID:162 (implicated_via_orthology)
Disease	urate measurement, bone density	DDX12P DSCAM ZNF618 AHCTF1 PKDCC CA10 FBXO42 TTLL1 PEAK1 ATP2B2 PRRC2B	6.82e-06	619	98	11	EFO_0003923, EFO_0004531
Disease	X-19141 measurement	UGT2B4 UGT2B7 UGT2B11	9.92e-06	13	98	3	EFO_0800799
Disease	diabetic retinopathy (is_implicated_in)	FLT1 AKR1B1 NOS3 SOD1	2.34e-05	50	98	4	DOID:8947 (is_implicated_in)
Disease	phosphatidylcholine 36:4 measurement	UGT2B4 UGT2B28 UGT2B11	2.80e-05	18	98	3	EFO_0010382
Disease	X-24947 measurement	UGT2B4 UGT2B7 UGT2B11	5.23e-05	22	98	3	EFO_0800910
Disease	Liver Cirrhosis, Experimental	CYBB PRUNE2 GPX8 DYSF CRY1 LIMK2 ROBO2 FGR AKR1B1 NOS3 HCK	5.32e-05	774	98	11	C0023893
Disease	Ovarian Mucinous Adenocarcinoma	SNRK ALPK1 HCK	1.49e-04	31	98	3	C1335167
Disease	rheumatoid arthritis (biomarker_via_orthology)	AZGP1 CHRNA7	1.62e-04	6	98	2	DOID:7148 (biomarker_via_orthology)
Disease	Diabetes Mellitus	CYBB ALPK1 SOD1	1.64e-04	32	98	3	C0011849
Disease	liver cirrhosis (biomarker_via_orthology)	FLT1 AZGP1 NOS3	1.97e-04	34	98	3	DOID:5082 (biomarker_via_orthology)
Disease	vanillylmandelate (VMA) measurement	UGT2B4 UGT2B10	2.27e-04	7	98	2	EFO_0800119
Disease	retinopathy of prematurity (is_implicated_in)	NOS3 SOD1	2.27e-04	7	98	2	DOID:13025 (is_implicated_in)
Disease	S-6-hydroxywarfarin measurement	AZGP1 DYSF YES1 HMCN1 UCHL5 ROBO2 PEAK1	2.32e-04	368	98	7	EFO_0803326
Disease	vitamin D deficiency	UGT2B4 UGT2B7 UGT2B11	2.54e-04	37	98	3	EFO_0003762
Disease	deoxycholic acid glucuronide measurement	UGT2B7 UGT2B10	3.02e-04	8	98	2	EFO_0800575
Disease	gastroesophageal reflux disease	SNRK CA10 PTPRT BTN1A1	3.65e-04	101	98	4	EFO_0003948
Disease	nasopharynx carcinoma (is_marker_for)	FLT1 SRC EZH2	3.98e-04	43	98	3	DOID:9261 (is_marker_for)
Disease	diabetic retinopathy (biomarker_via_orthology)	FLT1 AKR1B1 NOS3	4.56e-04	45	98	3	DOID:8947 (biomarker_via_orthology)
Disease	rheumatoid arthritis, systemic lupus erythematosus	PTPN22 BLK	4.83e-04	10	98	2	EFO_0000685, MONDO_0007915
Disease	end stage renal disease (biomarker_via_orthology)	CYBB ARG2 NOS3	5.18e-04	47	98	3	DOID:783 (biomarker_via_orthology)
Disease	diabetic angiopathy (is_marker_for)	F3 SOD1	7.05e-04	12	98	2	DOID:11713 (is_marker_for)
Disease	colorectal cancer (is_implicated_in)	SRC EZH2 PTPRT BUB1	7.22e-04	121	98	4	DOID:9256 (is_implicated_in)
Disease	vitamin D measurement	TDRD15 UGT2B4 UGT2B7 UGT2B10 PEAK1 UGT2B11	9.12e-04	336	98	6	EFO_0004631
Disease	Chromosome Breakage	EZH2 DDX11	9.68e-04	14	98	2	C0376628
Disease	Chromosome Breaks	EZH2 DDX11	9.68e-04	14	98	2	C0333704
Disease	hypertension (biomarker_via_orthology)	CYBB F3 ARG2 NOS3 SOD1	9.80e-04	227	98	5	DOID:10763 (biomarker_via_orthology)
Disease	colon cancer (is_marker_for)	AZGP1 SRC EZH2	1.01e-03	59	98	3	DOID:219 (is_marker_for)
Disease	Prostatic Neoplasms	IL24 AZGP1 ITSN1 EZH2 ARG2 LIFR ROBO2 NOS3	1.05e-03	616	98	8	C0033578
Disease	Malignant neoplasm of prostate	IL24 AZGP1 ITSN1 EZH2 ARG2 LIFR ROBO2 NOS3	1.05e-03	616	98	8	C0376358
Disease	disease progression measurement	UGT2B4 UGT2B7 UGT2B11	1.11e-03	61	98	3	EFO_0008336
Disease	Williams-Beuren syndrome (implicated_via_orthology)	SRC LIMK2	1.11e-03	15	98	2	DOID:1928 (implicated_via_orthology)
Disease	systemic lupus erythematosus (is_implicated_in)	PTPN22 BLK HSPA1L	1.17e-03	62	98	3	DOID:9074 (is_implicated_in)
Disease	infant expressive language ability	DSCAM ROBO2	1.27e-03	16	98	2	EFO_0006316
Disease	Pre-Eclampsia	FLT1 NOS3	1.27e-03	16	98	2	C0032914
Disease	Seasonal Affective Disorder	CRY1 PER3	1.27e-03	16	98	2	C0085159
Disease	diabetic retinopathy (implicated_via_orthology)	AKR1B1 NOS3	1.27e-03	16	98	2	DOID:8947 (implicated_via_orthology)
Disease	Kuhnt-Junius degeneration (is_implicated_in)	FLT1 NOS3	1.44e-03	17	98	2	DOID:10873 (is_implicated_in)
Disease	Uremia	FLT1 NOS3	1.44e-03	17	98	2	C0041948
Disease	non-alcoholic steatohepatitis (biomarker_via_orthology)	AZGP1 SOD1	1.44e-03	17	98	2	DOID:0080547 (biomarker_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	NOS3 SOD1	1.80e-03	19	98	2	DOID:0080322 (biomarker_via_orthology)
Disease	Mammary Carcinoma, Human	IL24 FLT1 SRC EZH2 F3 PER3 NOS3	1.86e-03	525	98	7	C4704874
Disease	Mammary Neoplasms, Human	IL24 FLT1 SRC EZH2 F3 PER3 NOS3	1.86e-03	525	98	7	C1257931
Disease	Mammary Neoplasms	IL24 FLT1 SRC EZH2 F3 PER3 NOS3	1.90e-03	527	98	7	C1458155
Disease	Antihypertensive use measurement	YES1 TNRC6A AKR1B1 ATP2B2 NOS3	1.94e-03	265	98	5	EFO_0009927
Disease	esophagus squamous cell carcinoma (is_marker_for)	AZGP1 EZH2 CHRNA7	1.94e-03	74	98	3	DOID:3748 (is_marker_for)
Disease	Fetal Growth Retardation	NOS3 SOD1	2.00e-03	20	98	2	C0015934
Disease	polymyositis	PTPN22 BLK	2.00e-03	20	98	2	EFO_0003063
Disease	myocardial infarction (biomarker_via_orthology)	CYBB FLT1 F3 NOS3	2.03e-03	160	98	4	DOID:5844 (biomarker_via_orthology)
Disease	Breast Carcinoma	IL24 FLT1 SRC EZH2 F3 PER3 NOS3	2.14e-03	538	98	7	C0678222
Disease	Retinal Degeneration	ARG2 SOD1	2.20e-03	21	98	2	C0035304
Disease	Deep Vein Thrombosis	F3 F8	2.20e-03	21	98	2	C0149871
Disease	Venous Thrombosis	F3 F8	2.20e-03	21	98	2	C0042487
Disease	Cardiomegaly	SRC NOS3 MYBPC3	2.60e-03	82	98	3	C0018800
Disease	Cardiac Hypertrophy	SRC NOS3 MYBPC3	2.60e-03	82	98	3	C1383860
Disease	Weight decreased	ALPK1 SOD1	2.64e-03	23	98	2	C1262477
Disease	chronotype measurement	NOL4 ZNF618 EZH2 CA10 CRY1 PER3 RBM19 ROBO2 HCK	2.69e-03	882	98	9	EFO_0008328
Disease	Nerve Degeneration	CHRNA7 ARG2 SOD1	2.69e-03	83	98	3	C0027746
Disease	congenital diaphragmatic hernia (biomarker_via_orthology)	NOS3 SOD1	2.87e-03	24	98	2	DOID:3827 (biomarker_via_orthology)
Disease	lung adenocarcinoma (is_marker_for)	AZGP1 SRC EZH2	2.88e-03	85	98	3	DOID:3910 (is_marker_for)
Disease	Reperfusion Injury	CYBB NOS3 SOD1	3.28e-03	89	98	3	C0035126

Protein segments in the cluster

Peptide	Gene	Start	Entry
IFGKWPVVLITNPKS	TMEM62	306	Q0P6H9
QVFNAPKPKWTQLSG	ALKBH6	41	Q3KRA9
KVSLNPPWNRIFKGE	FCER1A	31	P12319
KKARAPQAFPAWPVA	C1orf167	1101	Q5SNV9
EGPGKNLPFSVENKW	COX7C	21	P15954
DEPFKPWKGLQTNFR	APOBEC3D	361	Q96AK3
LQDKVPQLPGFSWIK	ARG2	171	P78540
KVQKPANPWEFYIGT	BUB1	821	O43683
PEPQVQWRTSKGEKF	BTN1A1	171	Q13410
SGQWQVFGPDKPVQA	BTNL8	16	Q6UX41
FPVPEQFKTLWNGQK	CAP1	451	Q01518
PPNSQSKVDWGKFFL	ALDH3A2	441	P51648
AWFVPDIPQSVKNKV	ANO9	721	A1A5B4
KPVQVAGADWKDPSV	PPP1R13B	401	Q96KQ4
FTVDTFVVNKKPWLP	ATP2B2	416	Q01814
GVKTVRFPDGQIWKP	CHRNA7	96	P36544
FVPEKWQYKQAVGPE	ALPK1	61	Q96QP1
WKSPPGQVTEAVKVA	AKR1B1	21	P15121
WAPVGVFSSTAPQKK	RBM19	656	Q9Y4C8
KWQTKAFPIVGEPLQ	PTPN22	396	Q9Y2R2
VAEDVVFKPVAAPWN	AOC2	536	O75106
KWKVFNSSSVVGPPE	FBXO42	661	Q6P3S6
QGSKFPIKWTAPEAA	FGR	416	P09769
DPFPWQQKVRFAKGI	LIMK2	421	P53671
HVPPGFFEKTQNKAW	SMPDL3B	236	Q92485
VAGWGIFIKDPVQKN	EZH2	621	Q15910
WPFRVVSEGGKPKVQ	HSPA2	91	P54652
QKKETFPNVAEEPIW	PER3	1091	P56645
KQPQEAAVWRVQSPK	PCYOX1L	386	Q8NBM8
SPVRFFVDKKWNTIP	PEAK1	281	Q9H792
FSPWNSPVFVIQKKS	HERVK_113	66	P63132
LWPFQVINEGGKPKV	HSPA1L	91	P34931
AIKWNEANRPGKVPF	F8	1551	P00451
FASVTQPQKQPAWKT	AP5M1	186	Q9H0R1
GGVWKVIFKTPNQDT	PNMA2	86	Q9UL42
RPAGEPAWVTQFVQK	DDX11	106	Q96FC9
FSPWNSPVFVIQKKS	ERVK-7	66	P63135
FSPWNSPVFVIQKKS	ERVK-6	66	Q9BXR3
HWPFQVVSEGGKPKV	HSPA7	91	P48741
GKTEKNYNVNIWVPP	HMCN1	2181	Q96RW7
PKFPRVKNWEVGSIT	NOS3	66	P29474
KIYIQWKPPNETNGV	PTPRT	501	O14522
FSPWNSPVFVIQKKS	ERVK-18	66	Q9QC07
DFPWTNVGKLVFVGK	FRMD6	271	Q96NE9
GAKFPIKWTAPEAIN	HCK	416	P08631
AQEGAKFPIKWTAPE	BLK	391	P51451
AKPAVQAPWSTAEKG	ITSN1	716	Q15811
DPWNAPEGIQKVAKC	CRY1	446	Q16526
VWKFAQKVVPDPNVI	DDX19B	281	Q9UMR2
RPAGEPAWVTQFVQK	DDX11L8	106	A8MPP1
FGPCQVKGVVPQKLW	IL24	56	Q13007
PAGEPAWVTQFVQKK	DDX12P	126	Q92771
WGKIKECPIPQFAGN	CYBB	251	P04839
FQDAWKLPKIAVDGP	CYBB	376	P04839
FNPVSFTWKKIEPKG	KLHDC3	271	Q9BQ90
QPPVVLAVKEFSWQK	AHCTF1	76	Q8WYP5
KAQTGEVAAFKGWPP	DIP2A	466	Q14689
VNPEGQVVKFWKPEE	GPX8	171	Q8TED1
KEVVQGSFVPVPSFW	CA10	36	Q9NS85
FGVAWVEAFAKPVPQ	UTP3	181	Q9NQZ2
PPEGNIVAQVFKCIW	SLC15A2	246	Q16348
KVIKNSVNPVWNEGF	DYSF	36	O75923
WIPDSQTKVFPQDKV	LIFR	246	P42702
IVWKFSKGAGVPQFQ	DSCAM	721	O60469
ARQGAKFPIKWTAPE	SRC	421	P12931
NEKNVPEKWNPVAGI	TRMT13	316	Q9NUP7
GDVAWQISPKASFPK	PRUNE2	1796	Q8WUY3
FFKTGWSQVVPDPNK	PKDCC	471	Q504Y2
FANILPVGEKWSPKA	TDRD15	126	B5MCY1
EIVKKGQFPIPSITW	LILRA1	76	O75019
VEAKQKPGPSFASWF	NCKAP5	1496	O14513
KLTVQEFPGDKWNPI	SHROOM4	961	Q9ULL8
KTLEKIQFISPGQPW	ARHGAP5	436	Q13017
FEQKESNGPVKVWGS	SOD1	21	P00441
KAQFRQSWPTKIDVP	SNRK	356	Q9NRH2
WVKSKGFQLGQPDEV	NOL4	56	O94818
PQVWSETKSGVAPQK	OS9	281	Q13438
FSPWNSPVFVIQKKS	ERVK-25	66	P63136
FKWQPGEEPAGSVVQ	UCHL5	56	Q9Y5K5
PHQWVFPKDVVKQQG	RNF213	4301	Q63HN8
PNAPVTKAGWLFKQA	PLEKHA6	56	Q9Y2H5
SKNVFPDNWKVPQDG	STK3	421	Q13188
LWPQPGIKDSFQKVI	ZNF738	116	Q8NE65
PAVVEEKWKPQAQRN	ZNF618	431	Q5T7W0
FISQEQPKITKSWGP	ZNF268	66	Q14587
WKQEVQPEEPTFKGS	ZSCAN32	151	Q9NX65
IPQKVLWRFDGNKPD	UGT2B4	331	P06133
FSPWNSPVFVIQKKS	ERVK-10	66	P10266
FSPWNSPVFVIQKKS	ERVK-8	66	P63133
FSPWNSPVFVIQKKS	ERVK-11	66	Q9UQG0
NIVIVPKDGTGWANK	PRRC2B	76	Q5JSZ5
CQVQGDPQPTVRWKK	ROBO2	246	Q9HCK4
ETKGNPQPAVFWQKE	ROBO2	336	Q9HCK4
HRGFQSQVKKWPLQP	RRP8	281	O43159
FKTILEWEPKPVNQV	F3	51	P13726
IPQKVLWRFDGNKPD	UGT2B11	331	O75310
PKCPENGFWVVQLSK	TRIM17	381	Q9Y577
PFDPAAQITKQKWEA	AZGP1	156	P25311
TCPGWVNKNKPALEQ	ZNF502	16	Q8TBZ5
PQKVLWRFDGNKPDA	UGT2B10	331	P36537
FSPWNSPVFVIQKKS	ERVK-19	66	Q9WJR5
LQWPGKEPQVTFPIK	WDR25	96	Q64LD2
IPQKVLWRFDGNKPD	UGT2B28	331	Q9BY64
IPQKVLWRFDGNKPD	UGT2B7	331	P16662
GVPEPQITWFKNNHK	FLT1	686	P17948
KVWDVGQPGAKTPVA	TLE2	481	Q04725
KGGNKQEEAWINPFV	TNRC6A	1191	Q8NDV7
WNKSPPKEVLGNYEI	TTLL1	366	O95922
IPSWEKGPVNNEFGK	ZNF184	171	Q99676
PTVKPQTQGLAKDAW	YES1	256	P07947
PQEWRKEGTPGIFQK	MUC12	5416	Q9UKN1
FPKGQAWKVVLGIFQ	NLRP13	76	Q86W25
NVKWFKNGEEIIPGP	MYBPC1	371	Q00872
PFQGKPRPQVTWTKE	MYBPC3	996	Q14896